about
Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosisAllogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.Obesity, airway hyperresponsiveness, and inflammation.Pleiotropic functions of plasminogen activator inhibitor-1.The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysisRole of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.The IL-1 type 1 receptor is required for the development of LPS-induced airways diseasep75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.Acute pulmonary function response to ozone in young adults as a function of body mass indexUsing mouse genomics to understand idiopathic interstitial fibrosis.Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats.Toll-like receptor 4 antagonist (E5564) prevents the chronic airway response to inhaled lipopolysaccharide.Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse.
P2860
Q28386104-B7419E88-C06D-427A-9289-AD4ED911433EQ33638349-42287323-86B9-41D3-917E-3E17D3149837Q33727992-9345BC6E-B3CA-4E55-9969-D76953920C61Q33984228-0A0D3DD2-BF5A-459A-BCED-AB3D9AE38358Q34222527-8AB7E5BB-80FA-47FA-940C-C66A208AFCE6Q34924856-0607F234-EE66-4EE6-AF71-582CA412979DQ34969868-BEFAA61B-EC47-4374-AFC4-7A24A1A8FA34Q36060741-1D34182C-2776-4269-8C37-1E5565E49DE2Q36118647-A0C7CB70-225E-48EE-AE63-8F8AE8D389EDQ36477546-BC0651CB-62A0-42FA-99F8-877294B5F8CEQ36698831-AEC9CFB8-3D43-4196-B42D-215E83132397Q41695234-EEF41BA8-6A07-4FAD-A1D4-2A1C7D80FD1AQ45163924-04C15038-22C6-4FB9-97A7-70FC3905D13FQ46440232-8472342E-9679-4AAD-B874-FDA6407FF60CQ46497808-AA303CA0-0208-4A60-8AAA-2C62776FD679
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Fibrinolysis in LPS-induced chronic airway disease.
@en
Fibrinolysis in LPS-induced chronic airway disease.
@nl
type
label
Fibrinolysis in LPS-induced chronic airway disease.
@en
Fibrinolysis in LPS-induced chronic airway disease.
@nl
prefLabel
Fibrinolysis in LPS-induced chronic airway disease.
@en
Fibrinolysis in LPS-induced chronic airway disease.
@nl
P2093
P2860
P1476
Fibrinolysis in LPS-induced chronic airway disease.
@en
P2093
David A Schwartz
David M Brass
Erin McElvania
Jordan D Savov
Katherine G Berman
P2860
P304
P356
10.1152/AJPLUNG.00102.2003
P577
2003-06-20T00:00:00Z